IGFBP5 and Alzheimer disease: The presence of IGFBP5-IR in the hippocampus of AD brains strengthens the argument for a possible pathogenic role of IGFBP5 in AD, and the prominent expression in hippocampus could impair hippocampus-related cognitive functions.